Healthcare Facilities & Managed Care "2026 Star Ratings Recalculated" Rice

Research evidence excerpt

Healthcare Facilities & Managed Care "2026 Star Ratings Recalculated" Rice

Global Research

18 June 2026ab

Healthcare Facilities & Managed Care Equities

Americas2026 Star Ratings Recalculated

Healthcare Providers

AJ Rice

CMS Recalculates Star Ratings For Some- Benign Impact for Public MCOs but Analyst

Suggests Stars Declines if Metrics Removed aj.rice@ubs.com

On June 17, after the market close, CMS released a memo indicating it would voluntarily +1-212-713 4299

recalculate the 2027 Star ratings following the Clover Insurance company v Department Jonathan Yong

of Health & Human Services decision. As was similar to prior iterations where Stars were Analyst

recalculated, there is a hold harmless provision in the recalculation. That is, if a Star jonathan.yong@ubs.com

rating were to decline, the contract will not see its Stars rating updated. We recalculated +1-212-713 6268

the Star ratings for the publicly traded MCOs by removing the Part C and D metrics CMS Michael Wei

outlined and compared it against our original calculations. Broadly, there are few Associate Analyst

contracts that see score improvements within our analysis and only a handful of michael.wei@ubs.com

contracts that would actually see an actual Stars improvement. See Figure 1UNH,HUM,ELV,CNC,MOH,ALHC and Figure 2CLOV +1-212-713 2565

andCVS. Interestingly, under this specific construct of metrics removed, Clover actually does not James Kurek

improve to the 4.5 Star rating they were awarded. Collectively, at face value, the Analyst

recalculation is likely not a meaningful driver for the publicly traded companies (other james.kurek@ubs.com

than CLOV). With that, the recalculation does suggest there could be significant +1-212-713 3704